---
figid: PMC2474812__nihms52369f1
figlink: /pmc/articles/PMC2474812/figure/F1/
number: F1
caption: The classical and back-door pathways of androgen biosynthesis. In the classical
  pathway (solid gray arrow), C21 precursors (pregnenolone and progesterone) are converted
  to the C19 adrenal androgens dihydroepiandrosterone (DHEA) and androstenedione (AED)
  by the sequential hydroxylase and lyase activities of CYP17A1. Circulating adrenal
  androgens (including the sulfated form of DHEA, DHEA-S), enter the prostate and
  can be converted to testosterone by a series of reactions involving the activity
  of HSD3B, HSD17B and AKR1C enzymes. Testosterone is then converted to the potent
  androgen DHT by the activity of SRD5A. In the back-door pathway to DHT synthesis
  (short gray arrows), C21 precursors are first acted upon by SRD5A and the reductive
  3α-hydroxysteroid dehydrogenase (3α-HSD) activity of AKR1C family members, followed
  by conversion to C19 androgens via the lyase activity of CYP17A, and subsequently
  to dihydrotestosterone (DHT) by the action of HSD17B3 and an oxidative 3α-HSD enzyme.
pmcid: PMC2474812
papertitle: 'Intracrine androgen metabolism in prostate cancer progression: mechanisms
  of castration resistance and therapeutic implications.'
reftext: Elahe A. Mostaghel, et al. Best Pract Res Clin Endocrinol Metab. ;22(2):243-258.
pmc_ranked_result_index: '36075'
pathway_score: 0.8881205
filename: nihms52369f1.jpg
figtitle: Classical and back-door pathways of androgen biosynthesis
year: ''
organisms:
- Homo sapiens
ndex: 3348c804-dea1-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2474812__nihms52369f1.html
  '@type': Dataset
  description: The classical and back-door pathways of androgen biosynthesis. In the
    classical pathway (solid gray arrow), C21 precursors (pregnenolone and progesterone)
    are converted to the C19 adrenal androgens dihydroepiandrosterone (DHEA) and androstenedione
    (AED) by the sequential hydroxylase and lyase activities of CYP17A1. Circulating
    adrenal androgens (including the sulfated form of DHEA, DHEA-S), enter the prostate
    and can be converted to testosterone by a series of reactions involving the activity
    of HSD3B, HSD17B and AKR1C enzymes. Testosterone is then converted to the potent
    androgen DHT by the activity of SRD5A. In the back-door pathway to DHT synthesis
    (short gray arrows), C21 precursors are first acted upon by SRD5A and the reductive
    3α-hydroxysteroid dehydrogenase (3α-HSD) activity of AKR1C family members, followed
    by conversion to C19 androgens via the lyase activity of CYP17A, and subsequently
    to dihydrotestosterone (DHT) by the action of HSD17B3 and an oxidative 3α-HSD
    enzyme.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKR1C3
  - CYP11A1
  - CYP17A1
  - STS
  - AKR1C2
  - AKR1C1
  - HSD3B1
  - UGT2B17
  - SRD5A1
  - HSD17B2
  - CYP7B1
  - HSD17B3
  - CYP19A1
  - AKR1C4
  - UGT2B15
  - Aldosterone
  - Androstenedione
  - Androsterone
  - Cholesterol
  - Corticosterone
  - Cortisone
  - DHEA
  - Estradiol
  - Estrone
  - Cortisol
  - 5a-Pregnane
  - Pregnane
  - 17a-OH Pregnenolone
  - Pregnenolone
  - OH Progesterone
  - Progesterone
  - Testosterone
  - 5-Androstenediol
  - glucuronides
genes:
- word: AKR1C3
  symbol: AKR1C3
  source: hgnc_symbol
  hgnc_symbol: AKR1C3
  entrez: '8644'
- word: CYP11A1
  symbol: CYP11A1
  source: hgnc_symbol
  hgnc_symbol: CYP11A1
  entrez: '1583'
- word: CYP17A1
  symbol: CYP17A1
  source: hgnc_symbol
  hgnc_symbol: CYP17A1
  entrez: '1586'
- word: STS
  symbol: STS
  source: hgnc_symbol
  hgnc_symbol: STS
  entrez: '412'
- word: AKR1C2
  symbol: AKR1C2
  source: hgnc_symbol
  hgnc_symbol: AKR1C2
  entrez: '1646'
- word: AKR1C1
  symbol: AKR1C1
  source: hgnc_symbol
  hgnc_symbol: AKR1C1
  entrez: '1645'
- word: HSD3B
  symbol: HSD3B
  source: hgnc_prev_symbol
  hgnc_symbol: HSD3B1
  entrez: '3283'
- word: UGT2B17
  symbol: UGT2B17
  source: hgnc_symbol
  hgnc_symbol: UGT2B17
  entrez: '7367'
- word: SRD5A1,2
  symbol: SRD5A1
  source: hgnc_symbol
  hgnc_symbol: SRD5A1
  entrez: '6715'
- word: HSD17B2
  symbol: HSD17B2
  source: hgnc_symbol
  hgnc_symbol: HSD17B2
  entrez: '3294'
- word: CYP7B1
  symbol: CYP7B1
  source: hgnc_symbol
  hgnc_symbol: CYP7B1
  entrez: '9420'
- word: HSD17B3
  symbol: HSD17B3
  source: hgnc_symbol
  hgnc_symbol: HSD17B3
  entrez: '3293'
- word: CYP19A1
  symbol: CYP19A1
  source: hgnc_symbol
  hgnc_symbol: CYP19A1
  entrez: '1588'
- word: 3a-HSD)
  symbol: 3-alpha-HSD
  source: hgnc_alias_symbol
  hgnc_symbol: AKR1C4
  entrez: '1109'
- word: UGT2B15
  symbol: UGT2B15
  source: hgnc_symbol
  hgnc_symbol: UGT2B15
  entrez: '7366'
- word: HSD3B1,2
  symbol: HSD3B1
  source: hgnc_symbol
  hgnc_symbol: HSD3B1
  entrez: '3283'
chemicals:
- word: Aldosterone
  source: MESH
  identifier: D000450
- word: Androstenedione
  source: MESH
  identifier: D000735
- word: Androsterone
  source: MESH
  identifier: D000738
- word: Cholesterol
  source: MESH
  identifier: D002784
- word: Corticosterone
  source: MESH
  identifier: D003345
- word: Cortisone
  source: MESH
  identifier: D003348
- word: DHEA
  source: MESH
  identifier: D003687
- word: Estradiol
  source: MESH
  identifier: D004958
- word: Estrone
  source: MESH
  identifier: D004970
- word: Cortisol
  source: MESH
  identifier: D006854
- word: 5a-Pregnane
  source: MESH
  identifier: D011278
- word: Pregnane
  source: MESH
  identifier: D011278
- word: 17a-OH Pregnenolone
  source: MESH
  identifier: D011284
- word: Pregnenolone
  source: MESH
  identifier: D011284
- word: OH Progesterone
  source: MESH
  identifier: D011374
- word: Progesterone
  source: MESH
  identifier: D011374
- word: Testosterone
  source: MESH
  identifier: D013739
- word: 5-Androstenediol
  source: MESH
  identifier: D015114
- word: glucuronides
  source: MESH
  identifier: D020719
diseases: []
figid_alias: PMC2474812__F1
redirect_from: /figures/PMC2474812__F1
figtype: Figure
---
